Doctor Thomas Samuel, MD works in the field of Oncology. He studied medicine at Stony Brook University School of Medicine. Thomas Samuel is also published. He has 1 publication published. The lastest publication: "Is the era of HER2 over? Pertuzumab in the neoadjuvant treatment of early HER2-positive breast cancer.' He accepts Medicare payments and is registered with Medicare.gov.
Dr. Steven G. Roshon, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Bruno R. Bastos, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Elizabeth R. Stone, MD |